Evidence-Based Complementary and Alternative Medicine / 2019 / Article / Tab 3

Review Article

Efficacy of Danshen Class Injection in the Treatment of Acute Cerebral Infarction: A Bayesian Network Meta-Analysis of Randomized Controlled Trials

Table 3

Results of the network meta-analysis of the whole blood low shear viscosity (lower left quarter) and plasma viscosity (upper right quarter).

A-0.34
(-0.67, -0.02)
-0.01
(-0.38, 0.36)
-0.53
(-0.79, -0.25)
-0.38
(-0.95, 0.2)
--0.15
(-0.54, 0.23)
-

-1.72
(-6.44, 2.96)
B0.33
(-0.1, 0.77)
-0.19
(-0.52, 0.15)
-0.04
(-0.61, 0.54)
-0.19
(-0.31, 0.69)
-

-0.09
(-4.73, 4.53)
1.63
(-4.52, 7.82)
C-0.52
(-0.81, -0.23)
-0.37
(-1.03, 0.29)
--0.14
(-0.68, 0.39)
-

-1.33
(-4.91, 2.24)
0.39
(-4.94, 5.74)
-1.24
(-4.71, 2.27)
D0.15
(-0.46, 0.75)
-0.37
(-0.1, 0.85)
-

-1.26
(-11.51, 9.03)
0.46
(-10.67, 11.54)
-1.16
(-10.34, 7.99)
0.08
(-9.83, 9.94)
E-0.22
(-0.46, 0.91)
-

-19.89
(-26.42, -13.4)
-18.17
(-26.23, -10.16)
-19.79
(-27.82, -11.77)
-18.55
(-25.93, -11.24)
-18.63
(-30.79, -6.51)
F--

-1.33
(-5.99, 3.3)
0.39
(-6.31, 6.93)
-1.24
(-7.72, 5.4)
0
(-5.83, 5.86)
-0.08
(-11.28, 11.1)
18.55
(10.54, 26.64)
G-

-0.59
(-9.67, 8.64)
1.13
(-9.13, 11.34)
-0.49
(-10.73, 9.79)
0.75
(-9.08, 10.55)
0.67
(-13.1, 14.53)
19.3
(8.18, 30.54)
0.75
(-9.4, 11.15)
H

A: WM; B: Danshen injection + WM; C: Fufang Danshen injection + WM; D: Danhong injection + WM; E: Danshenchuanxiongqin injection + WM; F: Sodium Tanshinone IIA Sulfonate injection + WM; G: Salvianolate injection + WM; H: Danshen Salvianolic Acids injection + WM. The result underlined meant it had statistical significant.